The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Doctors are still being paid by state Medicaid health insurance programs after being kicked out of another state's Medicaid system or the federal Medicare program.
(Reuters) — A doctor who took kickbacks from a Pennsylvania hospice involved in a multimillion-dollar fraud. An Ohio psychiatrist who billed for treating no-show patients. A Georgia optometrist who claimed he conducted 177 eye exams in 1 day.
Here's a look at some of the top legal news stories for medical device companies this week: Intarcia adds $225m for Type II diabetes trial; Gynesonics raises $3m for VizAblate fibroid device; Lombard Medical takes out $26m loan for Aorfix stent graft; Alliqua prices $30m offering; Contego Medical raises $6m for embolic filter tech